After Golden Cross, DiaMedica Therapeutics, Inc. (DMAC)'s Technical Outlook is Bright

Technical Analysis - DiaMedica Therapeutics, Inc. (DMAC) has reached a key level of support, indicating potential for upward movement [1] - A "golden cross" has occurred, with DMAC's 50-day simple moving average crossing above its 200-day simple moving average, signaling a bullish breakout [1] - Golden crosses are characterized by three stages: a downtrend, the crossover of moving averages, and an upward price trend [2] Performance Metrics - Over the past four weeks, DMAC's stock has gained 56.3%, reflecting strong performance [3] - The company currently holds a 2 (Buy) rating on the Zacks Rank, suggesting it may be poised for further breakout [3] Earnings Outlook - There have been no cuts to earnings estimates for the current quarter, with one revision higher in the past 60 days, indicating a positive earnings outlook [3] - The Zacks Consensus Estimate for DMAC has also increased, reinforcing the bullish sentiment [3][5]